Extreme pathways are a unique, network-based, mathematical definition of metabolic pathways and thus can be used to rigorously define and study the emergent properties of biological systems. They are derived directly from the stoichiometric matrix that represents a biochemical network and completely characterize all possible steady-state flux distributions through the network. Extreme pathways have already given many insightful conclusions about the topological properties of reconstructed reaction networks and their relationships to biological functionalities. However, the utility of extreme pathways is currently limited by the fact that the complete enumeration of genome-scale extreme pathways is computationally challenging. Additionally, the development of new analysis tools is needed to strengthen the link between extreme pathway properties and experimental data. Accordingly, our specific aims are to: (1) enable the efficient calculation of extreme pathways from genome-scale models; (2) apply the techniques developed in Specific Aim #1 to compute the extreme pathways for: (a) organelles (the mitochondria from Saccharomyces cerevisiae and chloroplasts from Arabidopsis thaliana), (b) growth condition dependent human pathogens (Helicobacter pylori and Haemophilus influenzae and others that may become available during the period of this proposal), and (c) a fully autonomous organism Escherichia coil); and (3) develop analysis tools to yield more biological meaning and relevance of extreme pathways by analyzing singular value decomposition (SVD) of extreme pathway matrices and converting the flux cone into a cone of kinetic constants (the K-cone) using measured concentrations (proteomics and metabolomic data). The concepts and analysis methods developed and verified to date must be moved forward to tie concepts directly to biological data and applications. If implemented, this proposed program will result in a significant advancement in our ability to study and characterize the capabilities of reconstructed networks and to relate in silico results to actual cellular functions.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM068837-02
Application #
6777029
Study Section
Special Emphasis Panel (ZRG1-SSS-Y (92))
Program Officer
Jones, Warren
Project Start
2003-07-15
Project End
2007-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
2
Fiscal Year
2004
Total Cost
$294,120
Indirect Cost
Name
University of California San Diego
Department
Engineering (All Types)
Type
Schools of Arts and Sciences
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Zielinski, Daniel C; Jamshidi, Neema; Corbett, Austin J et al. (2017) Systems biology analysis of drivers underlying hallmarks of cancer cell metabolism. Sci Rep 7:41241
Du, Bin; Zielinski, Daniel C; Kavvas, Erol S et al. (2016) Evaluation of rate law approximations in bottom-up kinetic models of metabolism. BMC Syst Biol 10:40
Zielinski, Daniel C; Filipp, Fabian V; Bordbar, Aarash et al. (2015) Pharmacogenomic and clinical data link non-pharmacokinetic metabolic dysregulation to drug side effect pathogenesis. Nat Commun 6:7101
Bordbar, Aarash; Nagarajan, Harish; Lewis, Nathan E et al. (2014) Minimal metabolic pathway structure is consistent with associated biomolecular interactions. Mol Syst Biol 10:737
Thomas, Alex; Rahmanian, Sorena; Bordbar, Aarash et al. (2014) Network reconstruction of platelet metabolism identifies metabolic signature for aspirin resistance. Sci Rep 4:3925
Bordbar, Aarash; Monk, Jonathan M; King, Zachary A et al. (2014) Constraint-based models predict metabolic and associated cellular functions. Nat Rev Genet 15:107-20
Chang, Roger L; Xie, Lei; Bourne, Philip E et al. (2013) Antibacterial mechanisms identified through structural systems pharmacology. BMC Syst Biol 7:102
Bordbar, Aarash; Mo, Monica L; Nakayasu, Ernesto S et al. (2012) Model-driven multi-omic data analysis elucidates metabolic immunomodulators of macrophage activation. Mol Syst Biol 8:558
Bordbar, A; Palsson, B O (2012) Using the reconstructed genome-scale human metabolic network to study physiology and pathology. J Intern Med 271:131-41
Schellenberger, Jan; Zielinski, Daniel C; Choi, Wing et al. (2012) Predicting outcomes of steady-state ýýýýC isotope tracing experiments using Monte Carlo sampling. BMC Syst Biol 6:9

Showing the most recent 10 out of 27 publications